Company profile for Addex Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. Allosteric modulators are an emerging class of small molecule drugs which have the potential to be more specific and confer significant therapeutic advantages over conventional "orthosteric" small molecule or biological drugs.Addex's allosteric modulator drug...
Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. Allosteric modulators are an emerging class of small molecule drugs which have the potential to be more specific and confer significant therapeutic advantages over conventional "orthosteric" small molecule or biological drugs.Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention - the Addex pipeline was generated from this pioneering allosteric modulator drug discovery platform.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
12, chemin des Aulx, Case postale 68, 1228 Plan-les-Ouates, Geneva
Telephone
Telephone
+41 22 884 1555
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/11/3203606/0/en/Addex-Amends-its-at-the-Market-Offering-Agreement-With-H-C-Wainwright-Co.html

GLOBENEWSWIRE
11 Dec 2025

https://www.globenewswire.com/news-release/2025/12/01/3196636/0/en/Addex-Therapeutics-to-Report-2025-Third-Quarter-Financial-Results-And-Host-Conference-Call-on-December-4-2025.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/10/29/3176123/0/en/Addex-Increases-Issued-Share-Capital-to-Create-Treasury-Shares.html

GLOBENEWSWIRE
29 Oct 2025

https://www.globenewswire.com/news-release/2025/09/30/3158259/0/en/Addex-Therapeutics-Reports-2025-Half-Year-and-Second-Quarter-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
30 Sep 2025

https://www.globenewswire.com/news-release/2025/09/26/3156819/0/en/Addex-Therapeutics-to-Report-2025-Half-year-and-Second-Quarter-Financial-Results-on-September-30-2025-and-Host-Conference-Call-on-October-1-2025.html

GLOBENEWSWIRE
26 Sep 2025

https://www.globenewswire.com/news-release/2025/09/23/3154386/0/en/Addex-Appoints-Bank-of-New-York-Mellon-as-Depositary-Bank.html

GLOBENEWSWIRE
23 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty